KMDA
Kamada Ltd.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
8.23
▲ 0.21 (2.62%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
8.07
Prev close
8.02
Day high
8.25
Day low
8.02
Volume
109.35K
Market cap
$475.40M
P/E (TTM)
21.68
52W range
6.50 – 9.35
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
4.15M
Total on file
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.50
Call-heavy session
Put / call open interest
0.38
Positioning, not flow
Max pain
7.50
-9.0% from spot
ATM implied vol
73.4%
Nearest strike to spot
Skew (10% OTM)
-10.9%
Calls bid over puts
Call volume
2
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
7.50
16 contracts
Heaviest put OI
7.50
6 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+8.71%
+10.1%
1M
+18.39%
+14.7%
3M
+5.37%
+2.3%
6M
-6.36%
-17.4%
YTD
+16.71%
+4.4%
1Y
+18.22%
-1.8%
3Y
+55.18%
-19.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$475.40M
Enterprise value$347.49M
Revenue (TTM)$181.68M
Gross profit$74.77M
EBITDA$38.91M
Net income$20.37M
EPS (TTM)$0.38
Free cash flow$11.08M
Total cash$73.15M
Total debt$11.64M
Book value / share$4.50
Shares outstanding57.69M
Float31.27M
Short % of float0.42%
Dividend yield3.53%
Beta (5Y)0.13
Short interest
Shares short
131.14K
Prior 153.34K
Change vs prior
-14.5%
Shorts covering
% of float
0.42%
Normal
% of shares out
0.23%
Against total outstanding
Days to cover
3.8
Liquid
Float
31.27M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E21.68
Forward P/E13.81
PEG ratio0.63
Price / sales—
Price / book1.83
EV / revenue1.91
EV / EBITDA8.93
Gross margin41.16%
Operating margin15.37%
Profit margin11.21%
Return on equity7.97%
Return on assets4.19%
Debt / equity4.49
Current ratio3.33
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $180.46M | $160.95M | $142.52M | $129.34M | +12.1% |
| Operating revenue | $180.46M | $160.95M | $142.52M | $129.34M | +12.1% |
| Cost of revenue | $104.05M | $90.99M | $87.03M | $82.64M | +14.4% |
| Gross profit | $76.41M | $69.97M | $55.49M | $46.70M | +9.2% |
| Research & development | $12.99M | $15.19M | $13.93M | $13.17M | -14.4% |
| Selling, general & admin | $33.84M | $30.83M | $27.45M | $25.06M | +9.8% |
| Total operating expense | $50.17M | $49.92M | $45.43M | $42.17M | +0.5% |
| Operating income | $26.23M | $20.05M | $10.06M | $4.53M | +30.8% |
| Net interest income | $1.06M | $1.46M | -$710.00K | -$823.00K | -27.5% |
| Pre-tax income | $23.47M | $13.33M | $8.43M | -$2.26M | +76.0% |
| Tax provision | $3.27M | -$1.13M | $145.00K | $62.00K | +389.8% |
| Net income | $20.20M | $14.46M | $8.28M | -$2.32M | +39.7% |
| Net income to common | $20.20M | $14.46M | $8.28M | -$2.32M | +39.7% |
| Basic EPS | 0.35 | 0.25 | 0.17 | -0.05 | +40.0% |
| Diluted EPS | 0.35 | 0.25 | 0.15 | -0.05 | +40.0% |
| EBIT | $24.33M | $13.99M | $9.73M | -$1.34M | +73.9% |
| EBITDA | $39.25M | $27.80M | $22.44M | $10.81M | +41.2% |
| Basic shares | 57.71M | 57.85M | 48.83M | 46.42M | -0.2% |
| Diluted shares | 57.71M | 57.85M | 53.68M | 46.42M | -0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $75.47M | $78.44M | $55.64M | $34.26M | — | -3.8% |
| Cash & short-term investments | $75.47M | $78.44M | $55.64M | $34.26M | — | -3.8% |
| Accounts receivable | $27.01M | $21.39M | $19.73M | $27.13M | — | +26.3% |
| Inventory | $84.94M | $78.82M | $88.48M | $72.52M | — | +7.8% |
| Total current assets | $193.07M | $184.35M | $169.96M | $139.00M | — | +4.7% |
| Property, plant & equipment | $50.27M | $45.86M | $35.98M | $28.73M | — | +9.6% |
| Goodwill & intangibles | $126.41M | $132.17M | $139.96M | $147.01M | — | -4.4% |
| Total assets | $378.71M | $372.25M | $354.91M | $322.38M | — | +1.7% |
| Total current liabilities | $47.39M | $49.39M | $49.59M | $75.70M | — | -4.0% |
| Current debt | — | — | — | $4.44M | $2.63M | — |
| Long-term debt | — | — | — | $12.96M | $17.41M | — |
| Total debt | $11.56M | $11.06M | $8.82M | $20.60M | — | +4.5% |
| Total liabilities | $109.64M | $112.79M | $110.89M | $146.36M | — | -2.8% |
| Retained earnings | -$17.07M | -$25.74M | -$40.20M | -$48.48M | — | +33.7% |
| Shareholder equity | $269.07M | $259.46M | $244.02M | $176.02M | — | +3.7% |
| Working capital | $145.68M | $134.96M | $120.37M | $63.30M | — | +7.9% |
| Net tangible assets | $142.66M | $127.29M | $104.07M | $29.01M | — | +12.1% |
| Shares issued | 57.69M | 57.51M | 57.48M | 44.83M | — | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $20.20M | $14.46M | $8.28M | -$2.32M | +39.7% |
| Depreciation & amortisation | $14.92M | $13.81M | $12.71M | $12.15M | +8.0% |
| Stock-based compensation | $845.00K | $874.00K | $1.31M | $1.15M | -3.3% |
| Change in working capital | -$17.68M | $11.41M | -$18.20M | $11.65M | -254.9% |
| Operating cash flow | $25.49M | $47.59M | $4.32M | $28.59M | -46.4% |
| Capital expenditure | -$9.85M | -$10.74M | -$5.85M | -$3.78M | +8.3% |
| Investing cash flow | -$9.84M | -$10.74M | -$5.84M | -$3.78M | +8.4% |
| Dividends paid | -$11.53M | $0 | $0 | — | — |
| Financing cash flow | -$18.34M | -$13.91M | $22.68M | -$9.34M | -31.9% |
| Free cash flow | $15.64M | $36.85M | -$1.53M | $24.80M | -57.6% |
| End cash position | $75.47M | $78.44M | $55.64M | $34.26M | -3.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $45.24M | $44.68M | $47.01M | $44.75M | $44.02M | +1.3% |
| Operating revenue | $45.24M | $44.68M | $47.01M | $44.75M | $44.02M | +1.3% |
| Cost of revenue | $26.12M | $27.71M | $27.25M | $25.82M | $23.27M | -5.7% |
| Gross profit | $19.12M | $16.97M | $19.76M | $18.93M | $20.75M | +12.7% |
| Research & development | $2.18M | $2.89M | $2.64M | $3.22M | $4.25M | -24.6% |
| Selling, general & admin | $9.98M | $7.18M | $9.32M | $8.63M | $8.71M | +38.9% |
| Total operating expense | $12.16M | $13.42M | $11.95M | $11.86M | $12.95M | -9.3% |
| Operating income | $6.95M | $3.55M | $7.82M | $7.07M | $7.79M | +95.8% |
| Net interest income | $237.00K | $183.00K | $271.00K | $261.00K | $342.00K | +29.5% |
| Pre-tax income | $5.39M | $4.73M | $6.37M | $5.75M | $6.61M | +13.9% |
| Tax provision | $1.26M | $1.17M | $1.07M | -$1.62M | $2.65M | +7.4% |
| Net income | $4.13M | $3.56M | $5.30M | $7.38M | $3.96M | +16.0% |
| Net income to common | $4.13M | $3.56M | $5.30M | $7.38M | $3.96M | +16.0% |
| Basic EPS | 0.07 | 0.06 | 0.09 | 0.13 | 0.07 | +16.7% |
| Diluted EPS | 0.07 | 0.06 | 0.09 | 0.13 | 0.07 | +16.7% |
| EBIT | $5.58M | $4.99M | $6.59M | $5.95M | $6.80M | +11.7% |
| EBITDA | $9.43M | $8.79M | $10.35M | $9.69M | $10.42M | +7.2% |
| Basic shares | 59.03M | 59.37M | 58.84M | 56.74M | 56.63M | -0.6% |
| Diluted shares | 59.03M | 59.37M | 58.84M | 56.74M | 56.63M | -0.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $32.92M | $75.47M | $72.00M | $65.98M | $76.25M | — | -56.4% |
| Cash & short-term investments | $73.15M | $75.47M | $72.00M | $65.98M | $76.25M | — | -3.1% |
| Accounts receivable | $36.52M | $27.01M | $31.38M | $30.50M | $27.88M | — | +35.2% |
| Inventory | $85.44M | $84.94M | $85.41M | $82.08M | $78.36M | — | +0.6% |
| Total current assets | $199.24M | $193.07M | $192.73M | $183.27M | $188.50M | — | +3.2% |
| Property, plant & equipment | $50.37M | $50.27M | $47.29M | $47.14M | $46.95M | — | +0.2% |
| Goodwill & intangibles | $125.99M | $126.41M | $129.50M | $129.95M | $131.74M | — | -0.3% |
| Total assets | $383.02M | $378.71M | $377.21M | $368.17M | $375.11M | — | +1.1% |
| Total current liabilities | $59.78M | $47.39M | $47.84M | $45.77M | $57.05M | — | +26.1% |
| Total debt | $11.64M | $11.56M | $11.47M | $11.41M | $11.10M | — | +0.7% |
| Total liabilities | $123.63M | $109.64M | $111.98M | $108.22M | $123.15M | — | +12.8% |
| Retained earnings | -$27.36M | -$17.07M | -$20.64M | -$25.93M | -$33.31M | — | -60.3% |
| Shareholder equity | $259.39M | $269.07M | $265.23M | $259.95M | $251.96M | — | -3.6% |
| Working capital | $139.46M | $145.68M | $144.90M | $137.50M | $131.45M | — | -4.3% |
| Net tangible assets | $133.40M | $142.66M | $135.73M | $130.00M | $120.22M | — | -6.5% |
| Shares issued | 57.69M | 57.69M | 57.68M | — | 57.51M | 57.51M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $4.13M | $3.56M | $5.30M | $7.38M | $3.96M | +16.0% |
| Depreciation & amortisation | $3.85M | $3.80M | $3.76M | $3.75M | $3.61M | +1.3% |
| Stock-based compensation | $800.00K | $458.00K | $117.00K | $95.00K | $175.00K | +74.7% |
| Change in working capital | -$12.12M | -$482.00K | -$1.55M | -$3.22M | -$12.43M | -2,414.5% |
| Operating cash flow | -$291.00K | $7.57M | $10.42M | $8.02M | -$513.00K | -103.8% |
| Capital expenditure | -$973.00K | -$2.77M | -$3.59M | -$2.01M | -$1.47M | +64.9% |
| Investing cash flow | -$41.20M | -$2.77M | -$3.59M | -$2.01M | -$1.46M | -1,384.6% |
| Dividends paid | $0 | $0 | $0 | -$11.53M | $0 | — |
| Financing cash flow | -$856.00K | -$1.18M | -$754.00K | -$16.12M | -$293.00K | +27.4% |
| Free cash flow | -$1.26M | $4.79M | $6.83M | $6.01M | -$1.98M | -126.4% |
| End cash position | $32.92M | $75.47M | $72.00M | $65.98M | $76.25M | -56.4% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.11 | 0.16 | +42.2% |
| Dec 2025 | 0.08 | 0.06 | -22.6% |
| Sep 2025 | 0.09 | 0.09 | -2.7% |
| Jun 2025 | 0.09 | 0.13 | +44.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.11 | 4 | $149.33M | -2.4% |
| Next quarter | 0.13 | 4 | $150.65M | +9.5% |
| Current year | 0.49 | 4 | $605.89M | +9.0% |
| Next year | 0.60 | 3 | $673.24M | +11.1% |
Analyst targets & ownership
Mean target$13.50
High target$15.00
Low target$11.00
Implied upside64.03%
Analyst count4
ConsensusSTRONG BUY
Strong buy / Buy0 / 3
Hold0
Sell / Strong sell0 / 0
Held by insiders7.20%
Held by institutions47.89%
Institutions holding69
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 9, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 15, 25 | Benchmark | MAINTAINED | Buy | Buy |
| Mar 21, 25 | Benchmark | INITIATED | — | Buy |
| Mar 6, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jan 10, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 14, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 15, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 3, 24 | Stifel | INITIATED | — | Buy |
| May 9, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Mar 7, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 14, 23 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 17, 23 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
Moving averages & technicals
SMA 10
7.58
+8.65% from price
SMA 20
7.36
+11.95% from price
SMA 50
7.29
+13.03% from price
SMA 100
7.67
+7.24% from price
SMA 200
7.75
+6.27% from price
EMA 12
7.65
+7.55% from price
EMA 26
7.45
+10.52% from price
EMA 50
7.43
+10.76% from price
RSI (14)
72.5
Overbought
MACD (12,26,9)
0.21
Hist 0.12
ATR (14)
0.25
3.07% of price
Realised vol 30D
33.4%
Annualised
Bollinger upper
8.12
20, 2σ
Bollinger lower
6.60
20, 2σ
50 / 200 cross
Death
7.29 vs 7.75
Trend bias
Above 200
+6.27%
Risk profile
Beta vs SPY
1.06
More volatile than market
Correlation to SPY
0.41
Loosely linked
Realised vol 30D
33.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-26.1%
Peak to trough
Max drawdown 5Y
-44.4%
Peak to trough
ATR 14
0.25
3.07% of price
Beta (reported)
0.13
5Y monthly, from filing
Dividends & splits
Forward rate$0.25 / yr
Forward yield3.53%
5-year avg yield—
Payout ratio71.43%
Ex-dividend dateMar 23, 2026
Next pay dateApr 7, 2026
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-08-17
Corporate Changes & Voting Matters
6-K · 2026-08-12
Corporate Changes & Voting Matters
6-K · 2026-08-05
Corporate Changes & Voting Matters
6-K · 2026-07-20
Corporate Changes & Voting Matters
6-K · 2026-07-13
Corporate Changes & Voting Matters
6-K · 2026-06-18
Corporate Changes & Voting Matters
6-K · 2026-06-01
Corporate Changes & Voting Matters
6-K · 2026-05-13
Headlines
Kamada (KMDA) Q2 2026 Earnings Call Transcript
Motley Fool · 3d ago
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
GlobeNewswire · 6d ago
Is Kamada (KMDA) a Solid Growth Stock? 3 Reasons to Think "Yes"
Zacks · 8d ago
KMDA or PRTA: Which Is the Better Value Stock Right Now?
Zacks · 8d ago
Wall Street Analysts Think Kamada (KMDA) Could Surge 79.06%: Read This Before Placing a Bet
Zacks · 8d ago
Should Value Investors Buy Kamada (KMDA) Stock?
Zacks · 9d ago
Kamada Ltd (KMDA) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Expansion ...
GuruFocus.com · 10d ago
Kamada Ltd. Q2 2026 Earnings Call Summary
Moby · 10d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.